U.S. Food et al., 2024-02-09: FDA warning letter to an online seller of IV fluid products, stating that the site distributes misbranded IV drugs in interstate commerce and that such products may be contaminated or contain different ingredients.
FDA has observed that www.ivsupplyclinic.com introduces into interstate commerce misbranded intravenous (IV) fluid drug products.
Body, first paragraph (web page, no pagination)
U.S. Food et al., 2024-02-09: FDA warning letter to an online seller of IV fluid products, stating that the site distributes misbranded IV drugs in interstate commerce and that such products may be contaminated or contain different ingredients. Regulatory action naming a commercial IV-hydration vendor; issued by CDER. No PDF edition confirmed – HTML-only warning letter; no archive snapshot needed for a federal record. The letter is a notice of violation, not a court finding. Study type: regulatory record.
